Evaluation of the Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Administered With or Without Yellow Fever Vaccine in US Adults.
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2014
At a glance
- Drugs CYD TDV (Primary) ; Yellow fever vaccine
- Indications Dengue; Yellow fever
- Focus Therapeutic Use
- Sponsors Sanofi; sanofi pasteur
- 01 May 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 29 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2011 New trial record